B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PDGFRA

MOLECULAR TARGET

platelet derived growth factor receptor alpha

UniProt: P16234NCBI Gene: 515661 compounds

PDGFRA (platelet derived growth factor receptor alpha) is targeted by 61 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PDGFRA

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1erlotinib5.55256
2imatinib5.47236
3alvocidib4.5291
4foretinib4.3476
5tozasertib4.3375
6vandetanib4.3073
7ponatinib4.2670
8ceritinib4.1965
9nilotinib4.1764
10bosutinib4.0858
11doramapimod4.0657
12quizartinib3.9953
13semaxanib3.9350
14midostaurin3.8546
15pazopanib3.6939
16vatalanib3.6939
17nintedanib3.6136
18regorafenib3.5634
19canertinib3.5333
20tae 6843.4330
21pexidartinib3.4330
22fedratinib3.4029
23bms 7776073.3728
24linifanib3.3327
25mln 80543.3327
26saracatinib3.3327
27neflamapimod3.3026
28tandutinib3.2224
29dovitinib3.0921
30jnj 77066213.0921
31at 92833.0921
32lestaurtinib3.0420
33lenvatinib3.0420
34defosbarasertib2.8917
35barasertib2.8917
36r 4062.8316
37cediranib2.8316
38infigratinib2.7715
39masitinib2.7715
40pha 6657522.7114
41plx 47202.7114
42crenolanib2.7114
43enmd 20762.7114
44kw 24492.6413
45tivozanib2.6413
46bemcentinib2.6413
47ast 4872.5612
48raf 2652.4811
49motesanib2.4811
50brivanib2.4811

Showing top 50 of 61 compounds. Use the BiohacksAI search to explore all PDGFRA modulators.

About PDGFRA as a Drug Target

PDGFRA (platelet derived growth factor receptor alpha) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 61 compounds with documented PDGFRA interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PDGFRA inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.